Javascript must be enabled to continue!
A model of canine leukocyte telomere dynamics
View through CrossRef
SummaryRecent studies have found associations of leukocyte telomere length (TL) with diseases of aging and with longevity. However, it is unknown whether birth leukocyte TL or its age‐dependent attrition – the two factors that determine leukocyte TL dynamics – explains these associations because acquiring this information entails monitoring individuals over their entire life course. We tested in dogs a model of leukocyte TL dynamics, based on the following premises: (i) TL is synchronized among somatic tissues; (ii) TL in skeletal muscle, which is largely postmitotic, is a measure of TL in early development; and (iii) the difference between TL in leukocytes and muscle (ΔLMTL) is the extent of leukocyte TL shortening since early development. Using this model, we observed in 83 dogs (ages, 4–42 months) no significant change with age in TLs of skeletal muscle and a shorter TL in leukocytes than in skeletal muscle (P < 0.0001). Age explained 43% of the variation in ΔLMTL (P < 0.00001), but only 6% of the variation in leukocyte TL (P = 0.035) among dogs. Accordingly, muscle TL and ΔLMTL provide the two essential factors of leukocyte TL dynamics in the individual dog. When applied to humans, the partition of the contribution of leukocyte TL during early development vs. telomere shortening afterward might provide information about whether the individual’s longevity is calibrated to either one or both factors that define leukocyte TL dynamics.
Title: A model of canine leukocyte telomere dynamics
Description:
SummaryRecent studies have found associations of leukocyte telomere length (TL) with diseases of aging and with longevity.
However, it is unknown whether birth leukocyte TL or its age‐dependent attrition – the two factors that determine leukocyte TL dynamics – explains these associations because acquiring this information entails monitoring individuals over their entire life course.
We tested in dogs a model of leukocyte TL dynamics, based on the following premises: (i) TL is synchronized among somatic tissues; (ii) TL in skeletal muscle, which is largely postmitotic, is a measure of TL in early development; and (iii) the difference between TL in leukocytes and muscle (ΔLMTL) is the extent of leukocyte TL shortening since early development.
Using this model, we observed in 83 dogs (ages, 4–42 months) no significant change with age in TLs of skeletal muscle and a shorter TL in leukocytes than in skeletal muscle (P < 0.
0001).
Age explained 43% of the variation in ΔLMTL (P < 0.
00001), but only 6% of the variation in leukocyte TL (P = 0.
035) among dogs.
Accordingly, muscle TL and ΔLMTL provide the two essential factors of leukocyte TL dynamics in the individual dog.
When applied to humans, the partition of the contribution of leukocyte TL during early development vs.
telomere shortening afterward might provide information about whether the individual’s longevity is calibrated to either one or both factors that define leukocyte TL dynamics.
Related Results
Telomere maintenance in African trypanosomes
Telomere maintenance in African trypanosomes
Telomere maintenance is essential for genome integrity and chromosome stability in eukaryotic cells harboring linear chromosomes, as telomere forms a specialized structure to mask ...
Leukocyte telomere length and chronic disease burden in an adult community sample: a cross-sectional study
Leukocyte telomere length and chronic disease burden in an adult community sample: a cross-sectional study
Abstract
Introduction
Telomere length is a biomarker of cellular aging and chronic disease risk, but its population-level...
Telomere Length Shortening in Langerhans Cell Histiocytosis.
Telomere Length Shortening in Langerhans Cell Histiocytosis.
Abstract
The purpose of this study was to analyze telomere lengths in Langerhans Cell Histiocytosis (LCH). LCH is a clonally derived, proliferative disorder of pheno...
Telomere Length in Patients with Transfusion-Dependent Thalassemia
Telomere Length in Patients with Transfusion-Dependent Thalassemia
Abstract
Background: Thalassemia is a hereditary hemolytic anemia with a severity ranging from mild, non-transfusion dependent to severe chronic anemia requiring lifelong t...
Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.
Telomere Length of Hematopoietic Cells in Long-Term Post-Autograft Survivors: No Evidence of Accelerated Replicative Cell Senescence Despite the Persistent Reduction of Both Committed and Immature Progenitor Cell Compartments.
Abstract
Telomere length is considered a valuable replicative capacity predictor of human hematopoietic stem cells. Indeed, a progressive telomere shortening affects...
Abstract 1772: A naturally occurring canine model of peripheral T-cell lymphoma, not otherwise specified
Abstract 1772: A naturally occurring canine model of peripheral T-cell lymphoma, not otherwise specified
Abstract
Despite being the most common subtype of human peripheral T-cell lymphoma (PTCL), PTCL-not otherwise specified (PTCL-NOS) remains a poorly understood diagno...
P-276 Telomeres cooperate in zygotic genome activation by affecting DUX4/Dux transcription
P-276 Telomeres cooperate in zygotic genome activation by affecting DUX4/Dux transcription
Abstract
Study question
Whether the activation of DUX4, a key inducer in the process of zygotic genome activation (ZGA), is asso...
Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia
Human leukocyte antigen-G upregulates immunoglobulin-like transcripts and corrects dysfunction of immune cells in immune thrombocytopenia
Human leukocyte antigen-G is a non-classical major histocompatibility complex class I antigen with potent immune-inhibitory function. Human leukocyte antigen-G benefit patients in ...

